Strosznajder J, Chalimoniuk M, Samochocki M
Laboratory of Cellular Signalling, Polish Academy of Sciences, Warsaw, Poland.
Neurochem Int. 1996 Apr;28(4):439-44. doi: 10.1016/0197-0186(95)00103-4.
Stimulation of glutamatergic NMDA receptor in adult rat hippocampal synaptoneurosomes induces statistically significant Ca(2+)-dependent liberation of arachidonic acid (AA) and nitric oxide (NO)-activated cGMP synthesis. NMDA acting for 5 min at 100 microM markedly increases, by approx. 25%, Ca(2+)-mediated AA release from phospholipids of hippocampal synaptoneurosomes. Prolonged stimulation of NMDA receptor up to 10 min has smaller stimulatory effect and enhances AA release by about 6%. Moreover, NMDA activates NO-dependent cGMP production by approx. 5 times more than the Ca2+ itself. Release of both these second messengers is completely blocked by the competitive NMDA antagonist, APV (100 microM). The NMDA-mediated cGMP elevation completely depends on NO action, and is abolished by the specific inhibitor of NO synthase, NG-nitro-L-arginine. Moreover, serotonin at 10 microM in the presence of 10 microM pargyline, potently decreases both Ca(2+)- and NMDA receptor-mediated AA and cGMP release in hippocampal synaptoneurosomes. The agonist of 5-HT1A receptor, buspirone, in a way similar to serotonin itself, counteracts the Ca(2+)- and also NMDA receptor-evoked AA release and cGMP accumulation. An antagonist of 5-HT1A receptor, NAN-190, eliminates the effect of serotonin and buspirone on AA and NO/cGMP liberation. An antagonist of serotonergic 5-HT2 receptor, ketanserin, has no effect on the Ca2+ and serotonin action. These results indicate that serotonin, through 5-HT1A receptor, potently antagonizes the action of excitatory amino acid for AA release and NO/cGMP synthesis in the adult rat hippocampus. In conclusion, the interaction of serotonin with the glutamatergic system in the hippocampus may play an important role in the modulation of a signal transduction pathway, and by this molecular mechanism serotonin may exert a neuroprotective effect on hippocampal neurons.
刺激成年大鼠海马突触神经小体中的谷氨酸能NMDA受体可诱导具有统计学意义的、依赖于Ca(2+)的花生四烯酸(AA)释放以及一氧化氮(NO)激活的环鸟苷酸(cGMP)合成。100微摩尔的NMDA作用5分钟可使海马突触神经小体磷脂中Ca(2+)介导的AA释放显著增加,增幅约为25%。NMDA受体延长刺激至10分钟,刺激作用较小,使AA释放增加约6%。此外,NMDA激活的依赖于NO的cGMP生成量比Ca2+本身激活的量大约多5倍。这两种第二信使的释放均被竞争性NMDA拮抗剂APV(100微摩尔)完全阻断。NMDA介导的cGMP升高完全依赖于NO的作用,并被NO合酶的特异性抑制剂NG-硝基-L-精氨酸消除。此外,在存在10微摩尔优降宁的情况下,10微摩尔的5-羟色胺可有效降低海马突触神经小体中Ca(2+)和NMDA受体介导的AA及cGMP释放。5-HT1A受体激动剂丁螺环酮,与5-羟色胺本身类似,可对抗Ca(2+)以及NMDA受体诱发的AA释放和cGMP积累。5-HT1A受体拮抗剂NAN-190可消除5-羟色胺和丁螺环酮对AA以及NO/cGMP释放的影响。5-羟色胺能5-HT2受体拮抗剂酮色林对Ca2+和5-羟色胺的作用无影响。这些结果表明,5-羟色胺通过5-HT1A受体可有效拮抗成年大鼠海马中兴奋性氨基酸对AA释放以及NO/cGMP合成的作用。总之,5-羟色胺与海马中谷氨酸能系统的相互作用可能在信号转导通路的调节中起重要作用,通过这种分子机制,5-羟色胺可能对海马神经元发挥神经保护作用。